The Byers Center for Biodesign manages health technology grants for the Spectrum Pilot Grants Program. The defined scope of the Medtech component is to support projects involving medical devices and mobile technologies used for (1) therapeutic applications and (2) device-based patient-specific (or POC) diagnostic applications.
Byers Center for Biodesign - Medtech Pilot Grants must have the objective of translating discoveries into novel medtech products that address unmet medical needs. Emphasis will be placed on technologies that have the potential to advance rapidly into patient care through development by venture funded startups, licensing to established companies, or other pathways. Only projects involving Stanford-owned intellectual property will be considered. Examples include prototype device development, preclinical studies, and investigator-initiated pilot clinical studies.
Proposals should specifically address any or all of the following, as much as feasible:
- Underlying technology and preliminary data (if any)
- clinical indication and brief scope of market
- comparison to effectiveness and cost of current standard of care
- translational objectives that will be achieved with the funding
- development plan, including timeline and plans for funding post-award
- preliminary assessment of regulatory pathway, freedom to operate
- IP landscape and any significant non-Stanford collaborations - in particular those that would prevent independent development of the proposed technology/product
Deadline: Wednesday, May 1st, 2019, 6 p.m.
Institutional representatives: not applicable. Because this is an internal Stanford funding opportunity you do not have to submit your applications through your RPM in RMG or your CGO in OSR for their approval.
Amount of Funding:
Typical grants range between $15,000 and $50,000 per year and depend on the individual proposal. Awards will be granted for the period from August 1, 2019 through July 31, 2020.
Proposals will be evaluated by a committee of independent faculty and external reviewers, and awards will be based on individual selection criteria and scoring systems. In general, reviewers will select applications for consideration as finalists that have made convincing arguments that the investigator(s) is proposing a bold idea or approach that can have a major translational impact in translational research. Finalists will be invited for oral presentations.
Spectrum offers pilot grants for accelerating clinical and translational research in biomedical and health-related areas. The Spectrum MedTech Program has two major goals:
- to stimulate innovative clinical and translational research and
- to encourage collaborative, transdisciplinary work.
Our primary expectation is that these early-stage translational projects will lead to additional research, external support, information dissemination and most important, will develop into longer-term, comprehensive projects. We encourage transdisciplinary collaborations, but this is not a requirement for funding.
* Please see section application details below regarding IRB/APLAC approval process or see below, application instructions, for details on human or animal studies.
- Open to Stanford faculty with PI eligibility (with UTL, MCL, NTLR faculty appointments).
- Clinical Educator (CE) faculty, clinical instructors, instructors, graduate students and post-doctoral scholars (clinical and non-clinical) are required to include a PI-eligible faculty member as co-PI on the application.
Allowable expenditures include investigator’s salary, research personnel salaries, travel (if project-related) and project supplies. These grants do not include indirect cost expenses. Capital equipment costing more than $5,000, intellectual property services, and food (certain exceptions apply) are unallowable expenses.